BrightSpring Health Raises FY2026 Sales Guidance from $14.450B-$15.000B to $14.725B-$15.225B vs $14.847B Est
Full Year 2026 Financial GuidanceFor the full year 2026, BrightSpring is increasing Revenue and Adjusted EBITDA guidance, which excludes the Community Living business and the effects of any future closed acquisitions.
